Printer Friendly

COLUMBIA LABORATORIES EXPANDS WORLDWIDE MARKETING OF REPLENS(R) LOGOS AGREEMENT

 COLUMBIA LABORATORIES EXPANDS WORLDWIDE MARKETING
 OF REPLENS(R) LOGOS AGREEMENT
 HOLLYWOOD, Fla., June 12 /PRNewswire/ -- Columbia Laboratories, Inc. (AMEX: COB) today announced that Logos Pharmaceuticals (Pty) Limited will be the exclusive marketer of Replens(R) and Columbia's future women's health care products in the 16 countries of Sub Saharan Africa.
 Replens, marketed by Warner-Lambert in the U.S., is currently available in most European countries and England and Ireland. Replens is a non-hormonal moisturizer that addresses the problem of vaginal dryness, estimated to affect more than 70 million women in the United States and Europe and an estimated 3 million women in South Africa.
 Logos Pharmaceuticals is a subsidiary of Barlow Rand Limited. Barlow Rand is a diversified business group with interests in pharmaceuticals, mining, manufacturing, distribution, food and property with operations concentrated primarily in South Africa.
 Columbia Laboratories, Inc. is a U.S.-based multinational pharmaceutical company, established in 1987 ?dedicated primarily to developing and marketing women's health care products based on its patented bioadhesive drug delivery system.
 -0- 6/12/92
 /CONTACT: Margaret Roell, chief financial officer of Columbia Laboratories, 305-985-6545/
 (COB) CO: Columbia Laboratories, Inc.; Logo Pharmaceuticals (Pty) Limited ST: Florida IN: MTC SU: LIC


JB-AW -- FL002 -- 9562 06/12/92 09:32 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 12, 1992
Words:207
Previous Article:HALIFAX RELEASES YEAR-END RESULTS
Next Article:TEVA PHARMACEUTICALS TO MARKET COLUMBIA LABORATORIES' WOMEN'S HEALTH CARE PRODUCTS IN ISRAEL
Topics:


Related Articles
COLUMBIA LABORATORIES SIGNS LETTER OF INTENT TO LICENSE AND SUPPLY REPLENS AND OTHER WOMEN'S OTC HEALTH CARE PRODUCTS
WARNER-LAMBERT COMPANY TO MARKET COLUMBIA LABORATORIES' REPLENS: AGREEMENT SIGNED FOR LICENSE AND SUPPLY ARRANGEMENT
COLUMBIA LABORATORIES REPORTS FISCAL 1991 RESULTS; OPERATING AND NET LOSSES DECREASE
COLUMBIA LABORATORIES REPORTS WARNER-LAMBERT TO MARKET REPLENS IN CANADA
COLUMBIA LABORATORIES AND KODAK UNIT SIGN AGREEMENT TO EXPAND MARKETING OF REPLENS INTO JAPAN
ABBOTT AND SMITHKLINE BEECHAM SIGN MARKETING AND DISTRIBUTION AGREEMENT
LILLY AND RANBAXY FORM A GLOBAL ALLIANCE
ROBERTS PHARMACEUTICAL OBTAINS EXCLUSIVE CANADIAN RIGHTS TO REPLENS FROM COLUMBIA LABORATORIES
Meridian Enters Agreement with Mylan for Development of Generic Drug Line
Advanced Polymer Systems Announces Expanded Agreement With Dermik Laboratories And Initiation of Phase III Study of Microsponge(R)-Entrapped...

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters